ArticleBlood advances2020
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.
Filippo Spriano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this papercites it
ArticleBlood advances2020
Filippo Spriano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.